MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 11, 2005; DOI: 10.1124/mol.104.007427


0026-895X/05/6704-1283-1290$20.00
Mol Pharmacol 67:1283-1290, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.007427v1
67/4/1283    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Federici, M.
Right arrow Articles by Mercuri, N. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Federici, M.
Right arrow Articles by Mercuri, N. B.
Original Article

Trace Amines Depress GABAB Response in Dopaminergic Neurons by Inhibiting G-{beta}{gamma}-Gated Inwardly Rectifying Potassium Channels

Mauro Federici, Raffaella Geracitano, Alessandro Tozzi, Patrizia Longone, Silvia Di Angelantonio, C. Peter Bengtson, Giorgio Bernardi, and Nicola B. Mercuri

Experimental Neurology Laboratory, S. Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy; and University of Rome "Tor Vergata", Rome, Italy

Abstract

Trace amines (TAs) are present in the central nervous system in which they up-regulate catecholamine release and are implicated in the pathogenesis of addiction, attention-deficit/hyper-activity disorder, Parkinson's disease, and schizophrenia. By using intracellular and patch-clamp recordings from dopaminergic cells in the rat midbrain slices, we report a depressant postsynaptic action of two TAs, {beta}-phenylethylamine ({beta}-PEA) and tyramine (TYR) on the GABAB-mediated slow inhibitory postsynaptic potential and baclofen-activated outward currents. {beta}-PEA and TYR activated G-proteins, interfering with the coupling between GABAB receptors and G-{beta}{gamma}-gated inwardly rectifying potassium channels. This is the first demonstration that {beta}-PEA and TYR depress inhibitory synaptic potentials in neurons of the central nervous system, supporting their emerging role as neuromodulators.


Received September 20, 2004; accepted January 10, 2005

Address correspondence to: Dr. Nicola Biagio Mercuri, Department of Experimental Neurology, S. Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy. E-mail: mercurin{at}med.uniroma2.it




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. A. Pietsch, T. S. Scanlan, and R. J. Anderson
Thyronamines Are Substrates for Human Liver Sulfotransferases
Endocrinology, April 1, 2007; 148(4): 1921 - 1927.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
H. A. Navarro, B. P. Gilmour, and A. H. Lewin
A Rapid Functional Assay for the Human Trace Amine-Associated Receptor 1 Based on the Mobilization of Internal Calcium
J Biomol Screen, September 1, 2006; 11(6): 688 - 693.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics